<?xml version="1.0" encoding="UTF-8"?>
<p>Two cycles of combination therapy with the established MTD of tranilast will then be given to 50 patients. Their data will be compared with historical control data from patients who previously received conventional preoperative adjuvant chemotherapy (5-FU/CDDP) in our institute. This clinical study will be stopped when grade 4 toxicity occurs at the MTD of tranilast in &gt;5 patients.</p>
